• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尾加压素II基因在日本人群2型糖尿病遗传易感性中的作用。

Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects.

作者信息

Wenyi Z, Suzuki S, Hirai M, Hinokio Y, Tanizawa Y, Matsutani A, Satoh J, Oka Y

机构信息

Division of Molecular Metabolism and Diabetes, Department of Internal Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.

出版信息

Diabetologia. 2003 Jul;46(7):972-6. doi: 10.1007/s00125-003-1145-1. Epub 2003 Jun 27.

DOI:10.1007/s00125-003-1145-1
PMID:12830381
Abstract

AIM/HYPOTHESIS: Urotensin II is a potent vasoactive hormone and the urotensin II gene (UTS2) is localized to 1p36-p32, one of the regions reported to show possible linkage with Type 2 diabetes in Japanese subjects. The aim of this study is to investigate a possible contribution of SNPs in the UTS2 gene to the development of Type 2 diabetes.

METHODS

We surveyed SNPs in the UTS2 gene in 152 Japanese subjects with Type 2 diabetes mellitus and two control Japanese cohorts: one consisting of 122 elderly subjects who met stringent criteria for being non-diabetic, including being older than 60 years of age with no evidence of diabetes (HbA(1c)<5.6%), and another 268 subjects with normal glucose tolerance.

RESULTS

We identified two SNPs with amino acid substitutions, designated T21M and S89N. The allele frequency of 89N was higher in Type 2 diabetic patients than in both elderly normal subjects (p=0.0018) and subjects with normal glucose tolerance (p=0.0011), whereas the allele frequency of T21M was essentially identical in these three groups. Furthermore, in the subjects with normal glucose tolerance, 89N was associated with higher insulin concentrations on oral glucose tolerance test, suggesting reduced insulin sensitivity in subjects with 89N.

CONCLUSION/INTERPRETATION: These results strongly suggest that the S89N polymorphism in the UTS2 gene is associated with the development of Type 2 diabetes, via insulin sensitivity, in Japanese subjects.

摘要

目的/假设:尾加压素II是一种强效血管活性激素,尾加压素II基因(UTS2)定位于1p36 - p32,该区域据报道在日本人群中可能与2型糖尿病存在连锁关系。本研究的目的是调查UTS2基因中的单核苷酸多态性(SNP)对2型糖尿病发生发展的可能作用。

方法

我们在152名日本2型糖尿病患者以及两个日本对照队列中调查了UTS2基因中的SNP:一个队列由122名符合严格非糖尿病标准的老年受试者组成,包括年龄大于60岁且无糖尿病证据(糖化血红蛋白(HbA1c)<5.6%),另一个队列由268名糖耐量正常的受试者组成。

结果

我们鉴定出两个有氨基酸替换的SNP,分别命名为T21M和S89N。2型糖尿病患者中89N的等位基因频率高于老年正常受试者(p = 0.0018)和糖耐量正常的受试者(p = 0.0011),而T21M的等位基因频率在这三组中基本相同。此外,在糖耐量正常的受试者中,89N与口服葡萄糖耐量试验中较高的胰岛素浓度相关,提示携带89N的受试者胰岛素敏感性降低。

结论/解读:这些结果强烈表明,在日本人群中,UTS2基因中的S89N多态性通过胰岛素敏感性与2型糖尿病的发生有关。

相似文献

1
Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects.尾加压素II基因在日本人群2型糖尿病遗传易感性中的作用。
Diabetologia. 2003 Jul;46(7):972-6. doi: 10.1007/s00125-003-1145-1. Epub 2003 Jun 27.
2
Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese.日本人群中尾加压素II及尾加压素II受体基因的遗传变异与2型糖尿病风险
Peptides. 2004 Oct;25(10):1803-8. doi: 10.1016/j.peptides.2004.03.030.
3
Association of resistin (rs3745367) and urotensin II (rs228648 and rs2890565) gene polymorphisms with risk of type 2 diabetes mellitus in Indian population.抵抗素(rs3745367)和尾加压素 II(rs228648 和 rs2890565)基因多态性与印度人群 2 型糖尿病发病风险的关联。
Mol Biol Rep. 2020 Dec;47(12):9489-9497. doi: 10.1007/s11033-020-05991-6. Epub 2020 Dec 2.
4
Association between Thr21Met and Ser89Asn polymorphisms of the urotensin-II (UTS2) gene, diabetes mellitus, and diabetic retinopathy.尾加压素 II (UTS2) 基因 Thr21Met 和 Ser89Asn 多态性与糖尿病、糖尿病视网膜病变的关系。
Curr Eye Res. 2012 Oct;37(10):921-9. doi: 10.3109/02713683.2012.688181. Epub 2012 May 15.
5
Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines.血浆尾加压素-2水平以及尾加压素-2基因的Thr21Met多态性而非Ser89Asn多态性与偏头痛相关。
J Headache Pain. 2016;17:36. doi: 10.1186/s10194-016-0623-z. Epub 2016 Apr 18.
6
A polymorphism in the AMPKalpha2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population.AMPKα2亚基基因中的一种多态性与日本人群的胰岛素抵抗和2型糖尿病相关。
Diabetes. 2006 Apr;55(4):919-23. doi: 10.2337/diabetes.55.04.06.db05-0727.
7
Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance.尾加压素II基因和尾加压素II受体基因中的单倍型与胰岛素抵抗及糖耐量受损相关。
Peptides. 2006 Jul;27(7):1659-67. doi: 10.1016/j.peptides.2006.02.008. Epub 2006 Apr 4.
8
Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM.胰岛素受体底物-1基因密码子972多态性与糖耐量减低及晚发型非胰岛素依赖型糖尿病
Diabetes Care. 1998 May;21(5):753-6. doi: 10.2337/diacare.21.5.753.
9
[Genetic variations of urotensin II gene in type 2 diabetes].[2型糖尿病中尾加压素II基因的遗传变异]
Nihon Rinsho. 2005 Feb;63 Suppl 2:193-7.
10
[Role of urotensin II gene in the genetic susceptibility to gestational diabetes mellitus in northern Chinese women].[尾加压素II基因在中国北方女性妊娠期糖尿病遗传易感性中的作用]
Zhonghua Fu Chan Ke Za Zhi. 2006 Nov;41(11):732-5.

引用本文的文献

1
Role of Rs228648 and Rs2890565 single nucleotide polymorphisms in Urotensin-2 gene in prostate cancer.Urotensin-2基因中Rs228648和Rs2890565单核苷酸多态性在前列腺癌中的作用
Mol Biol Rep. 2025 Jun 9;52(1):572. doi: 10.1007/s11033-025-10662-5.
2
Urotensin II system in chronic kidney disease.慢性肾脏病中的尾加压素II系统
Curr Res Physiol. 2024 May 7;7:100126. doi: 10.1016/j.crphys.2024.100126. eCollection 2024.
3
Expression profiles of east-west highly differentiated genes in Uyghur genomes.维吾尔族基因组中东西方高度分化基因的表达谱

本文引用的文献

1
Is urotensin-II the new endothelin?尾加压素II是新的内皮素吗?
Br J Pharmacol. 2002 Nov;137(5):579-88. doi: 10.1038/sj.bjp.0704924.
2
Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.来自小鼠和猴子的编码尾加压素 II 肽及其同源 G 蛋白偶联受体的基因的分子和药理学特性
Br J Pharmacol. 2002 May;136(1):9-22. doi: 10.1038/sj.bjp.0704671.
3
Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p.
Natl Sci Rev. 2023 Mar 21;10(4):nwad077. doi: 10.1093/nsr/nwad077. eCollection 2023 Apr.
4
Genetic polymorphisms of rs2890565 Ser89Asn in coronary heart disease and myocardial infarction in Chinese population.中国人群中冠心病和心肌梗死相关的rs2890565基因多态性(Ser89Asn)
Int J Clin Exp Pathol. 2018 Apr 1;11(4):2125-2136. eCollection 2018.
5
Urotensin-II gene rs228648 polymorphism associated with the risk of diabetes mellitus.尿皮质素-II 基因 rs228648 多态性与糖尿病风险相关。
Biosci Rep. 2018 Dec 7;38(6). doi: 10.1042/BSR20181275. Print 2018 Dec 21.
6
Lack of association between urotensin-II (UTS2) gene polymorphisms (Thr21Met and Ser89Asn) and migraine.尿皮质素-II (UTS2) 基因多态性(Thr21Met 和 Ser89Asn)与偏头痛之间缺乏关联。
Bosn J Basic Med Sci. 2017 Aug 20;17(3):268-273. doi: 10.17305/bjbms.2017.2138.
7
Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines.血浆尾加压素-2水平以及尾加压素-2基因的Thr21Met多态性而非Ser89Asn多态性与偏头痛相关。
J Headache Pain. 2016;17:36. doi: 10.1186/s10194-016-0623-z. Epub 2016 Apr 18.
8
The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer.UTS2基因多态性和血浆尾加压素II水平在乳腺癌中的作用。
Tumour Biol. 2015 Jun;36(6):4427-32. doi: 10.1007/s13277-015-3082-2. Epub 2015 Jan 22.
9
Population pharmacodynamic modeling of hyperglycemic clamp and meal tolerance tests in patients with type 2 diabetes mellitus.2 型糖尿病患者高血糖钳夹和耐量试验的群体药效动力学建模。
AAPS J. 2013 Oct;15(4):1051-63. doi: 10.1208/s12248-013-9512-4. Epub 2013 Aug 1.
10
A closer look at the role of urotensin II in the metabolic syndrome.深入探讨尾加压素 II 在代谢综合征中的作用。
Front Endocrinol (Lausanne). 2012 Dec 28;3:165. doi: 10.3389/fendo.2012.00165. eCollection 2012.
在日本患病同胞对中进行的全基因组2型糖尿病搜索,证实了3号染色体长臂、15号染色体长臂和20号染色体长臂上的易感基因,并在7号染色体短臂和11号染色体短臂上鉴定出两个新的候选基因座。
Diabetes. 2002 Apr;51(4):1247-55. doi: 10.2337/diabetes.51.4.1247.
4
Insulin resistance and vascular function.胰岛素抵抗与血管功能。
J Diabetes Complications. 2002 Jan-Feb;16(1):92-102. doi: 10.1016/s1056-8727(01)00209-4.
5
Urotensin II evokes potent vasoconstriction in humans in vivo.尾加压素II在人体内可引起强烈的血管收缩。
Br J Pharmacol. 2002 Jan;135(1):25-7. doi: 10.1038/sj.bjp.0704448.
6
Inhibition of insulin release by urotensin II--a study on the perfused rat pancreas.
Horm Metab Res. 2001 Jun;33(6):379-81. doi: 10.1055/s-2001-15414.
7
Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.
Trends Cardiovasc Med. 2000 Aug;10(6):229-37. doi: 10.1016/s1050-1738(00)00069-4.
8
Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries.人尾加压素II是大鼠小动脉中的一种内皮依赖性血管舒张剂。
Br J Pharmacol. 2000 Aug;130(8):1865-70. doi: 10.1038/sj.bjp.0703513.
9
Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.鉴定尾加压素II作为孤儿G蛋白偶联受体GPR14的内源性配体。
Biochem Biophys Res Commun. 1999 Dec 9;266(1):174-8. doi: 10.1006/bbrc.1999.1796.
10
Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction.鉴定参与血管收缩调节的孤儿G蛋白偶联受体的天然配体。
Nat Cell Biol. 1999 Oct;1(6):383-5. doi: 10.1038/14081.